Jian-mei Hou

发表

Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.

Caroline Dive, Lee Lancashire, Robert Sloane, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved Therapeutic Effectiveness by Combining Recombinant CXC Chemokine Ligand 10 with Cisplatin in Solid Tumors

Xia Zhao, L. Tian, Yu‐quan Wei, 2005, Clinical Cancer Research.

ImprovedTherapeutic Effectiveness by Combining Recombinant CXCChemokine Ligand 10 with Cisplatin in SolidTumors

Xia Zhao, Yu‐quan Wei, J. Hou, 2005 .

Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability

F. Gao, Li Yang, Jiyan Liu, 2011, Journal of Molecular Medicine.

Prognostic influence of metformin as first‐line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes

F. Gao, Jiyan Liu, H. Dong, 2011, Cancer.

Tumorigenesis and Neoplastic Progression Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy

Caroline Dive, Lee Lancashire, Andrew Hughes, 2010 .

Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma

L. Tian, L. Zhang, J. Hou, 2006, Gene Therapy.

Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells.

C. Dive, F. Blackhall, J. Hou, 2012, Lung cancer.

Circulating tumor cells as a window on metastasis biology in lung cancer.

Caroline Dive, Robert Sloane, Andrew Hughes, 2011, The American journal of pathology.

Circulating Tumor Cells, Enumeration and Beyond

T. Ward, C. Dive, F. Blackhall, 2010, Cancers.

Cancer immunotherapy of targeting angiogenesis.

L. Tian, Yu‐quan Wei, J. Hou, 2004, Cellular & molecular immunology.

Enhanced antitumor effect of the combination of tumstatin gene therapy and gemcitabine in murine models.

Xia Zhao, L. Tian, Yu‐quan Wei, 2005, Human gene therapy.

Interleukin-15 enhances T-cell responses by stimulation with dendritic cells

F. Gao, Jiyan Liu, H. Dong, 2011, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Comparative proteomic analysis of irinotecan-sensitive colorectal carcinoma cell line and its chemoresistant counterpart

Jiyan Liu, F. Bi, J. Hou, 2011, Anti-cancer drugs.

Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.

Caroline Dive, Lee Lancashire, Robert Sloane, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin

J. Hou, L. Tian, H. Deng, 2002, Gene Therapy.

Circulating tumour cells: their utility in cancer management and predicting outcomes

Caroline Dive, T. Ward, C. Dive, 2010, Therapeutic advances in medical oncology.

Immunotherapy of tumor by targeting angiogenesis

L. Tian, Yu‐quan Wei, J. Hou, 2004, Science in China Series C: Life Sciences.

Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2.

Xia Zhao, Jiyan Liu, L. Tian, 2003, Blood.

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

Caroline Dive, Lee Lancashire, Robert Sloane, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.